Title: Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo
Authors: de Haan, Willeke ×
Out, Ruud
Berbée, Jimmy F P
van der Hoogt, Caroline C
van Dijk, Ko Willems
van Berkel, Theo J C
Romijn, Johannes A
Jukema, J Wouter
Havekes, Louis M
Rensen, Patrick C N #
Issue Date: Dec-2008
Publisher: Academic Press
Series Title: Biochemical and Biophysical Research Communications vol:377 issue:4 pages:1294-8
Article number: 10.1016/j.bbrc.2008.10.147
Abstract: Apolipoprotein CI (apoCI) has been suggested to influence HDL metabolism by activation of LCAT and inhibition of HL and CETP. However, the effect of apoCI on scavenger receptor BI (SR-BI)-mediated uptake of HDL-cholesteryl esters (CE), as well as the net effect of apoCI on HDL metabolism in vivo is unknown. Therefore, we evaluated the effect of apoCI on the SR-BI-mediated uptake of HDL-CE in vitro and determined the net effect of apoCI on HDL metabolism in mice. Enrichment of HDL with apoCI dose-dependently decreased the SR-BI-dependent association of [(3)H]CE-labeled HDL with primary murine hepatocytes, similar to the established SR-BI-inhibitors apoCIII and oxLDL. ApoCI deficiency in mice gene dose-dependently decreased HDL-cholesterol levels. Adenovirus-mediated expression of human apoCI in mice increased HDL levels at a low dose and increased the HDL particle size at higher doses. We conclude that apoCI is a novel inhibitor of SR-BI in vitro and increases HDL levels in vivo.
ISSN: 0006-291X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science